Beard Bros Pharms

National News

Supreme Court Grants Extension in Cannabis Prohibition Case

Beard Bros Media
19 August 2025

The U.S. Supreme Court has approved a 60-day extension for marijuana companies challenging federal cannabis prohibition, signaling potential interest in a case that could reshape cannabis law nationwide. Justice Ketanji Brown Jackson granted the extension last Friday, on August 15, 2025, giving cannabis businesses until October 24 to file their

Texas Proposes Rules to Expand Medical Cannabis Access Further

Beard Bros Media
18 August 2025

Texas is taking steps to modernize its medical cannabis program through new proposed regulations that could dramatically improve patient access and treatment options. The Texas Department of State Health Services has unveiled draft rules that will allow physicians to request additional medical conditions for cannabis treatment and establish standards for

Meta’s Censorship of Cannabis is a Modern-Day Witch Hunt—And It’s Hurting Us All

Beard Bros Media
15 August 2025

For over a decade, Beard Bros Pharms has stood at the intersection of cannabis culture, education, and advocacy. Since the early 2010s, we’ve watched as the cannabis industry has matured from an underground movement to a multi-billion-dollar, job-generating legal industry. We've been a loud and proud part of that progress—spreading

Cannabis May Slow Brain Aging and Preserve Cognitive Function Per Study

Beard Bros Media
14 August 2025

Recent research using UK Biobank data suggests that cannabis use may positively impact cognitive function by potentially reversing certain aspects of cognitive aging, challenging long-standing assumptions about cannabis and brain health. The study, which analyzed data from over 25,000 participants, reveals fascinating insights into how cannabis affects the aging brain

How Real-World Data Can Unlock Cannabis’s Role in Opioid Reduction

Jenniffer Lucero
14 August 2025

The opioid epidemic continues to claim lives every day, with chronic pain patients often caught in the middle, overprescribed, under-supported, and lacking safer alternatives. But what if one of those alternatives is already here? Management Science Associates (MSA) is conducting research to determine whether medical cannabis could be part of